GlaxoSmithKline Consumer Healthcare Corporate Release_Paradontax Feb 2013
08 February 2013
GLAXOSMITHKLINE STRENTHENS ITS ORAL CARE PORTFOLIO IN INDIA
LAUNCHES A GUM BLEEDING SPECIALIST ‘PARODONTAX’ NATIONALLY
New Delhi, February 08, 2013: Taking forward its commitment of growing the oral care portfolio in India, GlaxoSmithKline today announced the launch of Parodontax – a toothpaste that helps in reducing bleeding in gums. Parodontax offers a sharply focused proposition and with this launch, GlaxoSmithKline ventures into the next big segment of oral care.
Parodontax is designed to reduce bleeding gums and help in reducing the incidence of tooth loss. The average incidence of bleeding gums globally is 33%. Hence, the problem of bleeding gums certainly exists in India, and the perfect solution is now available in Parodontax. It has a special formulation with 70% active ingredients as well as natural herbs as: Peppermint, Myrrh, Chamolie, Echinacea, Mineral Salt, Rhatany and Sage
Commenting on the launch, Mr. Jayant Singh, Executive Vice President, Marketing, GlaxoSmithKline Consumer Healthcare, India, said, “GSK understands the growing needs of oral care in India. Gum bleeding is a concern that plagues a majority of the Indian population; however, seldom do sufferers recognize it as a serious condition and hence keep it untreated. GSK is driven by bringing scientifically proven products to the consumers, and with this launch we are strengthening our oral care portfolio in the country. Parodontax is being launched with a single minded benefit of providing relief from gum bleeding.”
As a part of GlaxoSmithKline’s initiative to build and establish Parodontax, the launch will be supported by extensive advertising campaigns across print, television and outdoor platforms. Additionally, to create awareness and educate consumers about gum bleeding as a serious concern, GSK would undertake an exhaustive dentist engagement programm. Priced at Rs 50 and Rs 100 for 40 gms and 80 gms respectively, Parodontax is available across retail and modern trade outlets across India.
About GlaxoSmithKline Consumer Healthcare Ltd.
GSKCH is an associate of GlaxoSmithKline plc. of the U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2700 people.
GSKCH has a strong marketing and distribution network in India comprising over 550 wholesalers and direct coverage of over 6,00,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent household names such as Eno, Crocin and Iodex.
Media Contacts ______________________________________________________
Genesis Burson Marsteller
Genesis Burson Marsteller